Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 20/20 | 0.61 |
| ▸ | HTR2C | P28335 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5936029 | 0.84 | MCHR1 (0.85) | MCHR1KCNH2 | |
| SCHEMBL5936051 | 0.83 | MCHR1 (0.58) | MCHR1KCNH2 | |
| SCHEMBL5936171 | 0.83 | MCHR1 (0.84) | MCHR1KCNH2 | |
| SCHEMBL5936028 | 0.75 | MCHR1 (1.00) | MCHR1KCNH2 | |
| SCHEMBL5253452 | 0.75 | MCHR1 (0.71) | MCHR1HTR2CKCNH2 | |
| SCHEMBL5936142 | 0.74 | MCHR1 (0.85) | MCHR1KCNH2 | |
| SCHEMBL5255597 | 0.74 | MCHR1 (0.85) | MCHR1HTR2CKCNH2 | |
| SCHEMBL6237332 | 0.74 | MCHR1 (1.00) | MCHR1KCNH2 | |
| SCHEMBL5936175 | 0.74 | MCHR1 (0.71) | MCHR1KCNH2 | |
| SCHEMBL14565950 | 0.73 | MCHR1 (0.64) | MCHR1HTR2CKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060194871-A1 | Heterocyclic mchr1 antagoists | SMITHKLINE BEECHAM CORPORATION | 2006-08-31 | — | — | US | disclosed |
| WO-2004092181-A9 | HETEROCYCLIC MCHR1 ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2005-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060194871-A1 | Heterocyclic mchr1 antagoists | MCHR1, MCHR2, MC1R | MCHR1 1/4885HTR2C 147/4885KCNH2 4037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.